http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018035079-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9dc6b6ac0adc9f8712c9f13b22949d73 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-02 |
| filingDate | 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53ecde29246e3eb4d554201d3aa0ee08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14ec4a7adb0f15999f09a7d9b4fc406e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_477cc8f174a9c584bfecc8b91926afe9 |
| publicationDate | 2018-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2018035079-A |
| titleOfInvention | Anti-toxoplasma agent |
| abstract | Disclosed is a drug that acts on Toxoplasma gondii in a host cell containing bradyzoite but has low toxicity to the host cell and does not induce taxoid in bradyzoite. Prevention of toxoplasmosis such as visual impairment and toxoplasma encephalitis comprising piperazine compounds such as hydroxyzine, cetirizine, and cyclidine, isomers thereof, pharmaceutically acceptable salts thereof, and mixtures thereof as active ingredients. And / or an anti-toxoplasma agent effective for treatment. [Selection figure] None |
| priorityDate | 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.